Regulatory Innovation Revisited: Blending Patient Needs, Industry Imperatives, Health Policy, and Reimbursement

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Equity/Stock(s)/Options (Both) - Conformal Medical
• Grant Support/Research Contract (Institutional) - Abbott Vascular; Boston Scientific Corporation; Edwards Lifesciences; Medtronic; Gentuity